STAT

JUNE 14, 2024

While the best parts of biomedical innovation are represented by ringing the bell at a cancer hospital after the final round of chemotherapy, the worst are reminiscent of Frankenstein’s monster. As investigators continue to gain insight into the early days of Covid-19, the origins of the pandemic may be still up for debate. In addition, congressional investigations into the National Institutes of Health have revealed that scientists have conducted, or have been granted approval to conduct

Chemotherapy 363

Chemotherapy Hospitals 363

Pharma Times

JUNE 14, 2024

NSCLC accounts for around 85% of all lung cancer cases, particularly in non-smoking patients

153

153

STAT

JUNE 14, 2024

News watchers around the U.S. have likely seen the warnings: without certificate of need (CON) laws, hospitals will be forced to close their doors when for-profit organizations open and cherry pick commercially insured patients, leaving those in rural areas without care. The reality is that even with certificate of need laws in place, rural patients are already without care.

Hospitals 362

Hospitals 362

PharmaVoice

JUNE 14, 2024

While researchers gain ground understanding long COVID’s impact, viable treatments could still be a long way off.

147

147

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

STAT

JUNE 14, 2024

The federal government is rescoring the quality ratings of this year’s Medicare Advantage plans, which could lead to an additional $1 billion of taxpayer money flowing into the coffers of health insurance companies. Recent court decisions required the Biden administration to make these changes to insurers’ star ratings, many of which came in lower than companies had expected and cost them hundreds of millions of dollars in bonuses.

Health Insurance Companies 354

Health Insurance Companies 354

Pharma Times

JUNE 14, 2024

The installation will double the capacity of cancer genomic testing using robotic automation

146

146

The Pharmacist

JUNE 14, 2024

Large multiple pharmacies have delivered around 200,000 Pharmacy First consultations in under six months. Since 31 January, Company Chemists’ Association (CCA) member pharmacies have delivered 209,200 Pharmacy First consultations, the CCA said on Wednesday. CCA chief executive Malcolm Harrison said the strong patient interest demonstrated ‘that the service is here to stay’.

122

122

STAT

JUNE 14, 2024

WASHINGTON — Novo Nordisk CEO Lars Fruergaard Jørgensen will testify before the Senate after Sen. Bernie Sanders threatened to subpoena the company over its pricing of the popular diabetes drug Ozempic and the obesity drug Wegovy, the Senate health committee announced Friday. The agreement is a finale to a farcical public back-and-forth over apparent difficulties between the Senate health committee and Novo in scheduling a hearing.

Diabetes 341

Diabetes Drug Pricing 341

pharmaphorum

JUNE 14, 2024

Stay up-to-date with the latest news in clinical trials with highlights from NMD Pharma, Minoryx Therapeutics, Moonlake Immunotherapeutics, and Ipsen. Discover the groundbreaking developments from 10th to 14th June.

115

115

STAT

JUNE 14, 2024

LOS ANGELES – For the past two years, Walgreens has tried to leverage its nationwide footprint to recruit customers who pick up drugs at its stores into clinical trials , in an effort to diversify participation in studies of new medicines. Other retailers have struggled with similar efforts to expand beyond their core pharmacy operations. Last year, CVS ended its clinical trial endeavors after two years, and earlier this year, Walmart closed several of its medical clinics.

305

305

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

pharmaphorum

JUNE 14, 2024

Radiopharma firm Telix abandons Nasdaq listing plans Phil.

111

111

STAT

JUNE 14, 2024

A blockbuster arthritis drug from Novartis may face a limit on what Colorado health plans pay for the medicine after a state board determined the injectable treatment is “unaffordable” for patients. The Colorado Prescription Drug Affordability Board voted Friday to grant the designation to Cosentyx, which is used to treat conditions such as plaque psoriasis and psoriatic arthritis.

Drug Pricing 299

Drug Pricing 299

pharmaphorum

JUNE 14, 2024

DeepWell gamifies breathing therapy for mental health Phil.

110

110

STAT

JUNE 14, 2024

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others.  That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.

276

276

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

Express Pharma

JUNE 14, 2024

Lupin announced that the United States Food and Drug Administration has completed an inspection of its injectable facility in Nagpur, India. The inspection of the facility was carried out from June 10 to June 13, 2024 , and concluded with zero 483 observations. Nilesh Gupta, Managing Director, Lupin said, “We are pleased to have a successful outcome of the U.S.

110

110

The Pharmacist

JUNE 14, 2024

The national medical director at NHS England has expressed alarm at reports of weight loss medication being used inappropriately. Speaking at the NHS Confed Expo conference in Manchester this week, Professor Stephen Powis said that new weight loss drugs were going to be an ‘important part’ of the NHS’s approach to tackling obesity. But he […] The post NHSE medical director 'alarmed' by reports of inappropriate weight loss drug use appeared first on The Pharmacist.

108

108

Pharmaceutical Technology

JUNE 14, 2024

If exercised, the option would allow Takeda to license the TKI olverembatinib outside China, Hong Kong, Macau, Taiwan and Russia.

105

105

Express Pharma

JUNE 14, 2024

SKAN Research Trust, promoted by Indian entrepreneur Ashok Soota, and UK-based Quadram Institute Bioscience announced that they will apply the TraDIS-Xpress platform to study the action of traditional medical compounds on bacteria, thereby aiding in the reformulation and development of novel antibacterial regimens. TraDIS-Xpress is Quadram’s proprietary genetic sequencing platform that is working to uncover new antimicrobial agents and develop better prebiotics and probiotics for health promotio

Compounding 104

Compounding 104

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

Pharmaceutical Technology

JUNE 14, 2024

AbbVie has made a licence agreement with FutureGen Biopharmaceutical for developing FG-M701 for inflammatory bowel disease (IBD).

105

105

Express Pharma

JUNE 14, 2024

Sun Pharmaceutical Industries, (including its subsidiaries or associate companies) and Israel-based Moebius Medical presented data demonstrating the durability of pain relief achieved in symptomatic knee OA patients through 26 weeks post-injection of MM-II. The results, presented at EULAR 2024, are based on an analysis from the randomised, controlled, Phase 2b clinical study (NCT04506463).

101

101

Pharmaceutical Technology

JUNE 14, 2024

England’s NHS has reported an 18% increase in the number of people with non-diabetic hyperglycaemia, also known as pre-diabetes.

Diabetes 98

Diabetes 98

European Pharmaceutical Review

JUNE 14, 2024

AbbVie and FutureGen Biopharmaceutical (Beijing) Co., Ltd. have made a license agreement, whereby AbbVie will develop, manufacture and commercialise a next generation TL1A antibody for inflammatory bowel disease (IBD). FG-M701 is a fully human monoclonal antibody targeting TL1A. This target plays a role in inflammatory autoimmune diseases. While AbbVie is set to advance the monoclonal antibody through development and beyond, the treatment is currently in preclinical development.

98

98

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

pharmaphorum

JUNE 14, 2024

FDA widens label for BMS’ cancer drug Augtyro Phil.

Labelling 89

Labelling 89

The Pharmacist

JUNE 14, 2024

Pharmacies have been advised they should order alternative vaccines from an approved list, after Sanofi has said its recombinant quadrivalent influenza vaccine (QIVr) would not be available for this year’s flu programme. In addition, the start date for the 2024/25 adult flu vaccination campaign has been confirmed as 3 October, NHS England announced in this […] The post Adult flu campaign to start 3 October but QIVr vaccine unavailable appeared first on The Pharmacist.

Vaccines 88

Vaccines 88

World Pharma News

JUNE 14, 2024

Immune system cells called macrophages play an unexpected role in the complicated connection between obesity and cancer, a Vanderbilt University Medical Center-led research team has discovered. Obesity increases the frequency of macrophages in tumors and induces their expression of the immune checkpoint protein PD-1 - a target of cancer immunotherapies.

Immunity 88

Immunity Immunization 88

BioPharma Dive

JUNE 14, 2024

The Japanese pharma paid $100 million to secure option rights to an Ascentage drug. Elsewhere, J.P. Morgan Private Capital closed its first fund and the FDA gave new COVID shot advice.

70

70

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

PharmaTech

JUNE 14, 2024

Novel approaches against chronic inflammation could potentially prevent certain inflammatory diseases and neurological conditions.

69

69

BioPharma Dive

JUNE 14, 2024

The Australia-based company had proposed raising $202 million via an initial stock sale, but withdrew its filing, citing its shares’ recent price appreciation on Australia’s stock exchange.

70

70

Pharmafile

JUNE 14, 2024

AbbVie and FutureGen Biopharmaceutical have announced a license agreement for the development of FG-M701, a next-generation TL1A antibody for the treatment of inflammatory bowel disease (IBD), which is currently in preclinical development. The post AbbVie and FutureGen announce license agreement for IBD therapy appeared first on Pharmafile.

64

64

BioPharma Dive

JUNE 14, 2024

Following Roche, Merck and others into a hot field, the Humira maker will pay $150 million to license a preclinical TL1A antibody for IBD.

62

62

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management